CIMEX
Price
$27.36
Change
+$0.09 (+0.33%)
Updated
Jun 2 closing price
Net Assets
146.54B
FQTEX
Price
$14.98
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
625.77M
Interact to see
Advertisement

CIMEX vs FQTEX

Header iconCIMEX vs FQTEX Comparison
Open Charts CIMEX vs FQTEXBanner chart's image
CIMEX vs FQTEX Comparison Chart in %
View a ticker or compare two or three
VS
CIMEX vs. FQTEX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMEX is a Buy and FQTEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMEX has more cash in the bank: 147B vs. FQTEX (626M). FQTEX pays higher dividends than CIMEX: FQTEX (6.38) vs CIMEX (3.23). CIMEX was incepted earlier than FQTEX: CIMEX (24 years) vs FQTEX (7 years). CIMEX (0.83) is less costly to investors than FQTEX (0.08). FQTEX is a more actively managed with annual turnover of: 103.34 vs. CIMEX (65.00). FQTEX has a lower initial minimum investment than CIMEX: FQTEX (0) vs CIMEX (250). FQTEX annual gain was more profitable for investors over the last year : 26.61 vs. CIMEX (8.61). FQTEX return over 5 years is better than : 59.61 vs. CIMEX (23.26).
CIMEXFQTEXCIMEX / FQTEX
Total Expense Ratio0.830.00-
Annual Report Gross Expense Ratio0.830.081,038%
Fund Existence24 years7 years-
Gain YTD5.85110.00958%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets147B626M23,482%
Annual Yield % from dividends3.236.3851%
Returns for 1 year8.6126.6132%
Returns for 3 years35.1361.1757%
Returns for 5 years23.2659.6139%
Returns for 10 years76.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLPCX17.86N/A
N/A
JPMorgan US Large Cap Core Plus C
PICMX40.22N/A
N/A
Virtus KAR Mid-Cap Growth I
OIEJX26.85N/A
N/A
JPMorgan Equity Income R6
MXISX14.85N/A
N/A
Empower S&P SmallCap 600® Index Inv
RYOAX61.16N/A
N/A
Rydex Biotechnology H